J. Mardiak

547 total citations
18 papers, 206 citations indexed

About

J. Mardiak is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, J. Mardiak has authored 18 papers receiving a total of 206 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in J. Mardiak's work include Testicular diseases and treatments (6 papers), Cancer Treatment and Pharmacology (5 papers) and Renal cell carcinoma treatment (3 papers). J. Mardiak is often cited by papers focused on Testicular diseases and treatments (6 papers), Cancer Treatment and Pharmacology (5 papers) and Renal cell carcinoma treatment (3 papers). J. Mardiak collaborates with scholars based in Slovakia, United States and Belgium. J. Mardiak's co-authors include Cezary Szczylik, Ian D. Davis, C. Sternberg, Lini Pandite, Robert D. Hawkins, Lauren McCann, S. Špánik, V. Krčméry, J. Trupl and Zdenka Jesenská and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and European Journal of Cancer.

In The Last Decade

J. Mardiak

18 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Mardiak Slovakia 6 91 83 53 48 39 18 206
Ryan Baron United Kingdom 9 75 0.8× 140 1.7× 45 0.8× 15 0.3× 132 3.4× 16 407
Hotaka Kamasaki Japan 9 29 0.3× 162 2.0× 19 0.4× 12 0.3× 29 0.7× 24 282
Carolina Elosua Spain 6 30 0.3× 120 1.4× 28 0.5× 19 0.4× 34 0.9× 7 229
Ningning Yang China 8 44 0.5× 165 2.0× 22 0.4× 67 1.4× 70 1.8× 20 393
Florence S.G. Cheung Singapore 8 27 0.3× 218 2.6× 42 0.8× 45 0.9× 104 2.7× 11 391
Xidong Ma China 10 78 0.9× 50 0.6× 32 0.6× 42 0.9× 88 2.3× 26 227
Mushfiq Hassan Shaikh Canada 12 35 0.4× 133 1.6× 38 0.7× 69 1.4× 123 3.2× 32 378
Zhengfu He China 10 85 0.9× 120 1.4× 25 0.5× 62 1.3× 41 1.1× 43 288
Akanksha Anand Germany 7 46 0.5× 76 0.9× 23 0.4× 34 0.7× 99 2.5× 14 232
Natália R. Costa Portugal 10 116 1.3× 161 1.9× 5 0.1× 87 1.8× 62 1.6× 15 385

Countries citing papers authored by J. Mardiak

Since Specialization
Citations

This map shows the geographic impact of J. Mardiak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mardiak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mardiak more than expected).

Fields of papers citing papers by J. Mardiak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mardiak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mardiak. The network helps show where J. Mardiak may publish in the future.

Co-authorship network of co-authors of J. Mardiak

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mardiak. A scholar is included among the top collaborators of J. Mardiak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mardiak. J. Mardiak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Fizazi, Karim, Gwénaël Le Teuff, Aude Fléchon, et al.. (2024). Personalized Chemotherapy on the Basis of Tumor Marker Decline in Poor-Prognosis Germ-Cell Tumors: Updated Analysis of the GETUG-13 Phase III Trial. Journal of Clinical Oncology. 42(28). 3270–3276. 4 indexed citations
2.
3.
Vrdoljak, Eduard, Martin Gore, S. Leyman, et al.. (2015). Bisphosphonates in Patients with Renal Cell Carcinoma and Bone Metastases: A Sunitinib Global Expanded-Access Trial Subanalysis. Future Oncology. 11(20). 2831–2840. 8 indexed citations
4.
Jäger, Dirk, Jinan Ma, Ernesto Korbenfeld, et al.. (2011). 7151 POSTER PREDICT (Patient Characteristics in REnal Cell Carcinoma and Daily Practice Treatment With Sorafenib) Non-interventional Study – Final Report. European Journal of Cancer. 47. S520–S520. 3 indexed citations
5.
Mego, Michal, et al.. (2010). Inflammatory skin metastasis as a first sign of progression of lung cancer--a case report.. PubMed. 23(6). 449–51. 2 indexed citations
6.
Mego, Michal, Katarína Rejleková, Mária Rečková, et al.. (2009). Kinetics of tumor marker decline as an independent prognostic factor in patients with relapsed metastatic germ-cell tumors.. Neoplasma. 56(5). 398–403. 9 indexed citations
7.
Sternberg, C., Cezary Szczylik, J. Mardiak, et al.. (2009). A randomized, double-blind phase III study of pazopanib in treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC). Journal of Clinical Oncology. 27(15_suppl). 5021–5021. 82 indexed citations
8.
Mardiak, J., Michal Mego, Jana Obertová, et al.. (2005). Capecitabine in the treatment of metastatic colorectal cancer refractory to 5-fluorouracil chemotherapy. Journal of Clinical Oncology. 23(16_suppl). 3689–3689. 3 indexed citations
9.
Mardiak, J., Zuzana Syčová-Milá, Jana Obertová, et al.. (2005). Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study.. PubMed. 52(3). 243–7. 8 indexed citations
10.
Mardiak, J., Zuzana Syčová-Milá, Jana Obertová, et al.. (2004). Paclitaxel, ifosfamide, and cisplatin (TIP) salvage therapy for patients (pts) with relapsed testicular germ cell tumors (GCT). Journal of Clinical Oncology. 22(14_suppl). 4632–4632. 4 indexed citations
11.
Mardiak, J., Zuzana Syčová-Milá, Jana Obertová, et al.. (2004). Paclitaxel, ifosfamide, and cisplatin (TIP) salvage therapy for patients (pts) with relapsed testicular germ cell tumors (GCT). Journal of Clinical Oncology. 22(14_suppl). 4632–4632. 2 indexed citations
12.
Mardiak, J., et al.. (2003). Retrocaval ureter with ureteral carcinoma.. PubMed. 104(12). 408–10. 2 indexed citations
13.
Mardiak, J., et al.. (2000). Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors.. PubMed. 47(4). 239–43. 2 indexed citations
14.
Mardiak, J., et al.. (2000). Alpha 2-b interferon and farmarubicin in the prophylaxis of recurrence of superficial transitional cell carcinoma of the urinary bladder.. PubMed. 101(6). 317–20. 2 indexed citations
15.
Krčméry, V., Zdenka Jesenská, S. Špánik, et al.. (1997). Fungaemia due to Fusarium spp. in cancer patients. Journal of Hospital Infection. 36(3). 223–228. 45 indexed citations
16.
Krčméry, V., Zdenka Jesenská, J. Trupl, et al.. (1996). Invasive mold infections in cancer patients: 5 years' experience withAspergillus, Mucor, Fusarium andAcremonium infections. Supportive Care in Cancer. 4(1). 39–45. 23 indexed citations
17.
Koza, I, J. Mardiak, L Švancárová, et al.. (1992). Intensive combination chemotherapy (TTL-I protocol) of large cell and immunoblastic lymphomas--long-term observation.. PubMed. 39(1). 43–7. 2 indexed citations
18.
Koza, I, et al.. (1992). Candidosis, aspergillosis and zygomycosis in an oncology department. Mycoses. 35(7-8). 189–191. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan Baron Breakdown of academic impact, for papers by Hotaka Kamasaki Breakdown of academic impact, for papers by Carolina Elosua Breakdown of academic impact, for papers by Ningning Yang Breakdown of academic impact, for papers by Florence S.G. Cheung Breakdown of academic impact, for papers by Xidong Ma Breakdown of academic impact, for papers by Mushfiq Hassan Shaikh Breakdown of academic impact, for papers by Zhengfu He Breakdown of academic impact, for papers by Akanksha Anand Breakdown of academic impact, for papers by Natália R. Costa
Rankless by CCL
2026